NCT04828668View on ClinicalTrials.gov

Study to Evaluate Benefits & Safety of Endourage Formula C™ Oral Drops in People With Post-Acute COVID-19 Syndrome.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 2, 2021

Primary Completion Date

January 31, 2022

Study Completion Date

February 14, 2022

Conditions

Covid 19

Interventions

DIETARY_SUPPLEMENT

Targeted Wellness Formula C™ Sublingual Drops - 1200mg - 30 mL (Formula C)

Hemp seed oil

Trial Locations (1)

94945

Thomas P Young, Novato

All Listed Sponsors

lead

Endourage, LLC

INDUSTRY

NCT04828668 - Study to Evaluate Benefits & Safety of Endourage Formula C™ Oral Drops in People With Post-Acute COVID-19 Syndrome. | Biotech Hunter | Biotech Hunter